Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Zhangjiang Park and CRO Sundia MediTech Form Incubator

publication date: Feb 11, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Shanghai Zhangjiang (Group) Co., which operates the Zhangjiang Hi-Tech Park, has joined with CRO Sundia MediTech Company (桑迪亚医药技术(上海)有限公司) to expand the concept of a CRO. The two companies have formed a platform that combines Intellectual Property, CRO and Venture Capital services in one group, a biopharma incubator that includes its own CRO. The goal is take a young biopharma from original discovery into clinical trials. At the same time, the incubator will help draw the best young biopharmas to Zhangjiang Park. More details...

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...